Indiana has officially joined the growing list of states increasing regulatory oversight of medical spas. On March 5, 2026, Indiana Governor Mike Braun signed Senate Bill 282 (SB 282) into law. The legislation introduces new requirements for medical spas operating in the state, including mandatory registration, designation of a responsible practitioner, and adverse event reporting obligations. While most provisions of the law take effect July 1, 2026, medical spas have a longer runway. Practices have until January 1, 2027 to comply with the new medical spa registration framework. For owners and operators, this timeline provides an important opportunity to review existing structures and ensure compliance before the law becomes fully enforceable.
A New Regulatory Framework for Indiana Medical Spas
SB 282 establishes a formal regulatory framework for medical spas in Indiana for the first time. Historically, most medical spas in the state operated under general medical practice rules without a dedicated regulatory structure. That is now changing. Beginning January 1, 2027, medical spas will be required to register with the Indiana Medical Licensing Board and comply with new operational requirements designed to increase oversight and patient safety. The law reflects a broader national trend toward greater regulation of aesthetic medicine, particularly as the industry continues to grow rapidly.
Key Requirements Under SB 282
Mandatory Medical Spa Registration
Under the new law, any facility operating as a medical spa must register with the state. Practices will be required to disclose information about the facility, ownership structure, supervising physicians or practitioners, and the services being offered. This registration requirement effectively creates a state-level registry of aesthetic practices, something many states currently lack. For regulators, this provides greater visibility into a rapidly expanding industry. For operators, it introduces a new layer of regulatory oversight and accountability.
Designation of a Responsible Practitioner
Each registered medical spa must designate a responsible practitioner. This individual is responsible for ensuring the medical spa complies with applicable laws and regulations, including supervision requirements, clinical protocols, and patient safety standards. The responsible practitioner must be appropriately licensed and will likely serve as the primary point of accountability if compliance issues arise. For many practices, this role will be filled by a physician medical director or an advanced practice provider with supervisory responsibilities. Practices should carefully evaluate whether their current supervision structure aligns with this requirement.
Importantly, many medical spas rely on third-party companies that provide medical director services or Good Faith Exam (GFE) platforms. While these arrangements can support clinical workflows, they do not transfer regulatory responsibility away from the medical spa itself. Under Indiana’s new framework, the medical spa and its designated responsible practitioner remain accountable for ensuring that treatments are performed in compliance with applicable medical practice laws, supervision requirements, and patient safety standards.
In other words, outsourcing clinical oversight does not eliminate liability. Medical spas should carefully evaluate any third-party medical director or GFE arrangements to ensure that they provide genuine clinical oversight rather than merely administrative services.
Mandatory Adverse Event Reporting
SB 282 also introduces adverse event reporting obligations for medical spas. Practices will be required to report certain serious complications associated with treatments performed at the facility. While the exact reporting framework will be clarified through regulatory guidance, the intent is clear: regulators want increased transparency around complications occurring in aesthetic practices. Medical spas should begin preparing by implementing formal complication documentation procedures, internal incident reporting policies, and escalation protocols for serious events. Many practices currently lack structured systems for documenting and reporting adverse events.
Mobile Services Are Effectively Prohibited
Another notable provision of SB 282 addresses where medical spa services may be performed. The law provides that medical spas may not provide health care services or cosmetic and lifestyle treatments to consumers at locations other than the registered medical spa office, unless the services are being performed for educational or training purposes. In practice, this provision may significantly restrict mobile or pop-up treatment models that have become increasingly common in the aesthetics industry, such as traveling injector services, aesthetic events, or treatments provided in private homes, salons, or hotels. Once the law becomes fully effective, most services will likely need to be performed at the registered medical spa location rather than at off-site venues.
Practical Test for Whether SB 282 Applies
A facility will likely qualify as a medical spa under the law if it performs medical treatments, uses prescription drugs or injectables, and markets aesthetic, wellness, or longevity services to consumers. If all three elements are present, no matter what the business is called, the practice will likely be required to register as a medical spa by January 1, 2027.
Implications for Research Use Only Peptides
The law also reinforces compliance with the federal Food, Drug, and Cosmetic Act, meaning pharmacies cannot compound substances that are not approved drugs or permitted bulk ingredients under federal compounding rules. In practice, this will impact many peptides currently circulating in the U.S. market that are labeled “Research Use Only,” unless those substances are ultimately placed on the FDA’s Category 1 bulk compounding list.
Why This Law Matters Beyond Indiana
While SB 282 applies only to Indiana practices, its broader significance should not be overlooked. Across the United States, regulators are increasingly focused on medical spa oversight, injectable safety, supervision requirements, and complication reporting. Several states have already introduced or passed similar legislation, and others are actively considering it. The trend is clear: the medical aesthetics industry is moving toward greater regulatory structure, not less. For multi-state operators, this means compliance frameworks should be built with scalability in mind. What begins as a state-level requirement in one jurisdiction often becomes a model for other states to follow.
What Medical Spas Should Do Now
Although the registration requirement does not take effect until January 1, 2027, practices should not wait until the last minute to begin preparing. Medical spa owners should begin reviewing their corporate structure to ensure ownership and management arrangements comply with Indiana’s medical practice laws. They should confirm that their supervision model aligns with regulatory expectations and that the designated responsible practitioner has meaningful oversight over treatments performed at the facility. Practices should also establish written clinical protocols addressing treatment procedures, complication management, and patient safety standards. Finally, they should implement internal documentation systems for complications and adverse events so that they are prepared once formal reporting requirements take effect. Practices that begin preparing early will have a significantly smoother transition once the new regulatory framework becomes enforceable.
The Bottom Line
Indiana’s SB 282 represents a meaningful shift in how the state regulates medical spas. Beginning in 2027, practices will operate under a more formal regulatory structure that includes state registration, designated medical oversight, and complication reporting requirements. For responsible operators, the new framework should not be viewed as a burden. Instead, it reflects the continued evolution of aesthetic medicine into a more mature and regulated healthcare sector. The medical aesthetics industry continues to grow rapidly, and as it does, regulatory oversight is likely to follow. Practices that invest in compliance today will be far better positioned for the regulatory landscape of tomorrow.